{
  "label": "clinical_signal_03_dx_renal_biomarker_study_017",
  "artifact_type": "distractor_episode",
  "artifact_id": "sha256:d28a43c04084e9617c0ad04b0cb0c07232a14d007b1e87b85bc80c345bd4b0ac",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:c334c83f0e5586d31926bcb6e60115e9bfeccda6fed885884ee61b742c0bfe26"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:57:30.520550",
  "content": "## 2024-06-24 Daily Operations Summary\n\n### Enrollment\n- Total Enrolled: 89\n- Active: 79\n- Screen Failures Cumulative: 34\n- Withdrawals Cumulative: 10\n\n### Enrollment by Cohort\n- 10mg: 20\n- 25mg: 22\n- 50mg: 23\n- 100mg: 24\n\n### Biomarkers By Cohort\n#### 10mg\n- KIM-1 (ng/mL) Mean: 1.66\n- KIM-1 (ng/mL) SD: 0.3\n- NGAL (ng/mL) Mean: 40.3\n- NGAL (ng/mL) SD: 12.6\n- Cystatin C (mg/L) Mean: 1.01\n- Cystatin C (mg/L) SD: 0.14\n- eGFR (mL/min) Mean: 65.1\n- eGFR (mL/min) SD: 9.9\n- UACR (mg/g) Mean: 52.2\n- UACR (mg/g) SD: 11.7\n- Serum Creatinine (mg/dL) Mean: 1.05\n- Serum Creatinine (mg/dL) SD: 0.16\n- Urine Protein (mg/dL) Mean: 37.0\n- Urine Protein (mg/dL) SD: 9.0\n- Urine Output (mL/24h) Mean: 1695\n- Urine Output (mL/24h) SD: 397\n\n#### 25mg\n- KIM-1 (ng/mL) Mean: 1.03\n- KIM-1 (ng/mL) SD: 0.57\n- NGAL (ng/mL) Mean: 57.3\n- NGAL (ng/mL) SD: 13.4\n- Cystatin C (mg/L) Mean: 0.88\n- Cystatin C (mg/L) SD: 0.12\n- eGFR (mL/min) Mean: 77.2\n- eGFR (mL/min) SD: 10.6\n- UACR (mg/g) Mean: 124.7\n- UACR (mg/g) SD: 22.2\n- Serum Creatinine (mg/dL) Mean: 1.45\n- Serum Creatinine (mg/dL) SD: 0.17\n- Urine Protein (mg/dL) Mean: 11.8\n- Urine Protein (mg/dL) SD: 3.4\n- Urine Output (mL/24h) Mean: 1674\n- Urine Output (mL/24h) SD: 384\n\n#### 50mg\n- KIM-1 (ng/mL) Mean: 2.0\n- KIM-1 (ng/mL) SD: 0.26\n- NGAL (ng/mL) Mean: 54.1\n- NGAL (ng/mL) SD: 15.2\n- Cystatin C (mg/L) Mean: 0.96\n- Cystatin C (mg/L) SD: 0.13\n- eGFR (mL/min) Mean: 71.9\n- eGFR (mL/min) SD: 10.9\n- UACR (mg/g) Mean: 33.6\n- UACR (mg/g) SD: 10.1\n- Serum Creatinine (mg/dL) Mean: 1.19\n- Serum Creatinine (mg/dL) SD: 0.24\n- Urine Protein (mg/dL) Mean: 34.9\n- Urine Protein (mg/dL) SD: 9.3\n- Urine Output (mL/24h) Mean: 2005\n- Urine Output (mL/24h) SD: 351\n\n#### 100mg\n- KIM-1 (ng/mL) Mean: 1.2\n- KIM-1 (ng/mL) SD: 0.5\n- NGAL (ng/mL) Mean: 55.1\n- NGAL (ng/mL) SD: 13.6\n- Cystatin C (mg/L) Mean: 0.89\n- Cystatin C (mg/L) SD: 0.12\n- eGFR (mL/min) Mean: 62.3\n- eGFR (mL/min) SD: 9.8\n- UACR (mg/g) Mean: 110.5\n- UACR (mg/g) SD: 21.2\n- Serum Creatinine (mg/dL) Mean: 1.11\n- Serum Creatinine (mg/dL) SD: 0.13\n- Urine Protein (mg/dL) Mean: 38.3\n- Urine Protein (mg/dL) SD: 9.0\n- Urine Output (mL/24h) Mean: 1649\n- Urine Output (mL/24h) SD: 312\n\n### Dose Response\n- KIM-1 Dose Correlation (r): 0.548\n- NGAL Dose Correlation (r): 0.242\n- eGFR Dose Correlation (r): -0.353\n- UACR Dose Correlation (r): 0.349\n\n### Safety Labs\n- Hemoglobin (g/dL) Mean: 13.1\n- Hemoglobin (g/dL) SD: 1.0\n- Hematocrit (%) Mean: 40.9\n- Hematocrit (%) SD: 4.0\n- WBC (k/\u00b5L) Mean: 8.0\n- WBC (k/\u00b5L) SD: 1.6\n- Platelets (k/\u00b5L) Mean: 225\n- Platelets (k/\u00b5L) SD: 46\n- Sodium (mEq/L) Mean: 140.0\n- Sodium (mEq/L) SD: 2.2\n- Potassium (mEq/L) Mean: 4.0\n- Potassium (mEq/L) SD: 0.5\n- Bicarbonate (mEq/L) Mean: 22.1\n- Bicarbonate (mEq/L) SD: 2.4\n- Phosphorus (mg/dL) Mean: 3.5\n- Phosphorus (mg/dL) SD: 0.4\n\n### Adverse Events\n- AE ID: RB-AE-1725, Description: hyperkalemia, Grade: 1, Relatedness: unlikely related, Resolved: true, Cohort: 10mg\n- AE ID: RB-AE-1727, Description: peripheral edema, Grade: 1, Relatedness: unlikely related, Resolved: true, Cohort: 50mg\n- AE ID: RB-AE-1796, Description: back pain, Grade: 2, Relatedness: unlikely related, Resolved: true, Cohort: 25mg\n\n### Protocol Deviations\n- None\n\n### Events\n- Protocol training refresher completed for site coordinators\n- Renal ultrasound images uploaded to central imaging core\n\n### Notes\n- Week 17: Renal biomarker collection on schedule. 89 subjects enrolled across 4 cohorts. eGFR and urinary biomarkers within expected variability.",
  "metadata": {
    "episode_type": "distractor",
    "theme": "renal_biomarker_study",
    "theme_index": 0,
    "local_index": 17,
    "scope_id": "clinical_signal_03",
    "layer_name": "distractor_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "b39286bd69ab4fc400a914137914eaa7bda71068fc11fdf31fc1054c8fc775f5",
      "components": {
        "transform": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
        "inputs": "e1e99cb871eaf7b9"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
      "components": {
        "transform_id": "01137a4997b78f86",
        "source": "c42d9c6282d5331f",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}